- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05946408
Effects of Antenatal Exercises in Primagravida
Effects Of Supervised Antenatal Exercises On Low Back Pain And Depression In Primigravida
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
KPK
-
Peshawar, KPK, Pakistan, 25000
- Khyber Teaching Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primagravida
- Single pregnancy
- Diagnosed for risk of Prenatal depression on EDPS >10
- Pregnancy related Low back pain score of 3 to 8 on NPRS for at least 2 weeks.
- Females in 2nd Trimester of pregnancy
Exclusion Criteria:
- Any present or previous pelvic floor dysfunctions diagnosed by health professionals.
- Any physical disability causing inability to perform physical exercises.
- Any contraindications to physical activity according to ACOG
- Pelvic girdle pain (Anterior: Pubic symphysis, Posterior: SI joint Pain, Gluteal Pain, Piriformis syndrome).
- Rheumatoid disorders.
- Low back pain with radiation
- Not engaged in regular exercise.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Supervised Antenatal Exercises
Supervised antenatal exercises twice a week an antenatal education
|
Supervised antenatal exercises along with education twice a week. Protocol consists of warm up (10 min), Aerobic training (20 mins, 60-75% of max. HR), Strength training (25 minutes), followed by a cool down of 15 minutes. The Interventions to be provided for a period of 12 weeks. |
|
Active Comparator: Antenatal Education
Antenatal education only
|
Antenatal education at 12th week of pregnancy.
Which consists of education on Posture in pregnancy, Role of pelvic floor muscles, Labor and breathing and relaxation techniques.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Low back pain
Time Frame: 12th Week
|
Changes from baseline low back pain will be assessed on Numeric pain rating scale.
The scale ranges from 0 for no pain to 10 for worse pain.
|
12th Week
|
|
The Roland Morris Low Back Pain and Disability Questionnaire
Time Frame: 12th Week
|
Changes from baseline low back pain related disability will be assessed using Roland Morris low back pain and disability questionnaire.
It is a self-report questionnaire consisting of 24 questions that are scored on a dichotomous scale (yes/no).
The total score ranges from 0 to 24, with higher scores indicating greater disability.
|
12th Week
|
|
Beck depression inventory
Time Frame: 12th week
|
Changes from baseline antenatal depression will be assessed using Beck depression inventory.
A total score of 0-9: indicates minimal depression 10-18: indicates mild depression 19-29: indicates moderate depression 30-63: indicates severe depression.
Higher total scores indicate more severe depressive symptoms
|
12th week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Multidimensional Fatigue Inventory
Time Frame: 12th week
|
Changes from baseline fatigue will be assessed using Multidimensional Fatigue Inventory. The MFI is a 20-item scale designed to evaluate five dimensions of fatigue: general fatigue, physical fatigue, reduced motivation, reduced activity, and mental fatigue. Items are scored on a scale of 1 to 5. For the total score, a higher score represent greater fatigue. |
12th week
|
|
Fear of Childbirth Questionnaire
Time Frame: 12th week
|
Changes from baseline The Fear of Childbirth Questionnaire (FCQ) this is 20 item questionnaires for women who are pregnant.
Items are scored on a scale of 1 to 5. A higher score indicates greater fear
|
12th week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sarah Ehsan, PP-DPT, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REC/01546
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.